Sanara Ventures
Investment Details
Investor Type
Venture Capital
Asset Class Focus
Venture Capital
Stage Focus
Pre-Seed, Seed, Series A, Series B, Growth Stage
Geographical Focus
United States, United Kingdom, Canada, Germany, Japan, Australia, China, France, Italy, Denmark, Switzerland, Spain, South Korea, Austria, Netherlands, Sweden, Belgium, Israel, Norway, Finland
Industries Focus
- Healthcare
- HealthTech
- Digital Health
- Pharmaceuticals
- Medical Devices
- Diagnostics
- Medtech
- Biotechnology
- Medical Equipment
- Clinical Research
- Medical Technology
- E-health
- Telemedicine
- Health Informatics
- Bio-Convergence
Investment Size:
1,000,000 to 10,000,000 USD
Investor Details Founded: 2014
Sanara Ventures is a healthcare-focused venture capital firm investing in early-stage startups in Israel and globally. The firm specializes in medical devices, digital health, and bio-convergence technologies, aiming to deliver life-changing innovations to the medical community and patients worldwide. Sanara Ventures is backed by Philips Healthcare and Teva Pharmaceuticals, providing a unique model of continuous support with pre-seed, seed, and post-seed investments. The firm utilizes its international network to link entrepreneurs, industry experts, academics, and healthcare systems with continuous funding opportunities, seeking collaborations that keep it at the forefront of healthcare innovation. Sanara Ventures was established in 2014 and is headquartered in Ra’anana, Israel. Its portfolio includes companies such as NanoDrops, a seed-stage Israeli company developing a laser-based device combined with nanoparticle eye-drops for refractive correction of myopia and presbyopia. The firm is led by CEO Assaf Barnea, who has significant experience in building innovation platforms and commercialization processes in healthcare and cleantech. Sanara Ventures is committed to supporting exceptional founders in building meaningful global companies, leveraging its expertise and leadership in the healthcare sector to drive innovation and improve patient outcomes.
Requirements
- Innovative healthcare solutions
- Strong founding teams
- Scalable business models
- Global market potential
- Alignment with Sanara Ventures' strategic focus areas
Contact
[Official Website Hidden]
[HQ Location Hidden]
[Email Hidden]
[Contact Number Hidden]
Portfolio Companies
- NanoDrops
Mentioned In
-
$19.95
-
$19.95
-
$49.95
-
$19.95
-
$24.95
-
$24.95
Claim this Investor
Are you an official representative of Sanara Ventures?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim